Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology?
This review provides perspectives on the utility of magnetic resonance imaging (MRI) as a neuroimaging approach in the development of novel treatments for Alzheimer's disease. These considerations were generated in a roundtable at a recent Wellcome Trust meeting that included experts from acade...
Үндсэн зохиолчид: | Merlo Pich, E, Jeromin, A, Frisoni, G, Hill, D, Lockhart, A, Schmidt, M, Turner, M, Mondello, S, Potter, W |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
BioMed Central
2014
|
Ижил төстэй зүйлс
-
Advances in Cardiovascular Biomarker Discovery
-н: Crystal M. Ghantous, зэрэг
Хэвлэсэн: (2020-11-01) -
Multinuclear MRI in Drug Discovery
-н: Dorota Bartusik-Aebisher, зэрэг
Хэвлэсэн: (2022-10-01) -
Open drug discovery in Alzheimer's disease
-н: Alison D. Axtman, зэрэг
Хэвлэсэн: (2023-04-01) -
Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia
-н: Winchester, LM, зэрэг
Хэвлэсэн: (2023) -
The role of fMRI in drug discovery.
-н: Wise, R, зэрэг
Хэвлэсэн: (2006)